ALKBH5 regulates N(6)-methyladenosine (m6A) methylation of MG53 to attenuate myocardial infarction by inhibiting apoptosis and oxidative stress
Journal of Cardiovascular Pharmacology
NOVEMBER 16, 2023
Abstract: N(6)-methyladenosine (m6A) methylation modification is involved in the progression of myocardial infarction (MI). The ischemia/reperfusion (I/R) injury mouse model and hypoxia/reoxygenation (H/R) cell model were established. We observed that ALKBH5 and MG53 were highly expressed in MI.
Let's personalize your content